Related Experiment Video
Updated: Jul 15, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Blood pressure and risks of vascular complications after percutaneous coronary intervention
1Winchester Medical Center, VA 22602, USA. cdumont@valleyhealthlink.com
Insights
High systolic blood pressure increases vascular complications after percutaneous coronary intervention. Specific anticoagulants and hemostasis methods impact complication rates, guiding evidence-based care protocols.
Area of Science:
- Cardiology
- Interventional Cardiology
- Nursing Science
Background:
- Percutaneous coronary intervention (PCI) is a common procedure with significant patient numbers in the US.
- A need exists for evidence-based protocols to manage patients undergoing PCI and minimize complications.
- Vascular complications following PCI represent a significant concern for patient outcomes.
Purpose of the Study:
- To identify demographic, physician-sensitive, and nurse-sensitive factors contributing to vascular complications after PCI.
- To provide data for developing improved, evidence-based care protocols for PCI patients.
- To analyze the relative impact of various factors on the incidence of vascular complications.
Main Methods:
- A case-matched control study design was employed.
- Data were collected from 300 patients undergoing percutaneous coronary intervention.
- Specific demographic, physician-sensitive, and nurse-sensitive factors were analyzed for their association with vascular complications.
Main Results:
- Elevated mean systolic blood pressure (≥160 mm Hg) was associated with an 8-fold increased risk of vascular complications (P < .001).
- Heparin use (with or without glycoprotein IIb/IIIa inhibitors) increased complication risk threefold compared to bivalirudin (P = .008).
- AngioSeal hemostasis and a history of hypertension were associated with reduced complication rates (77% and 61% less likely, respectively; P = .031 and P = .005).
Conclusions:
- Systolic blood pressure management is critical for reducing vascular complications post-PCI.
- Anticoagulant choice and hemostasis technique significantly influence complication incidence.
- These findings support the refinement of clinical protocols for percutaneous coronary intervention care.
Abstract:
Evidence-based protocols are needed for care of the nearly 1,000,000 patients in the United States who undergo percutaneous coronary interventional procedures. This article describes a case-matched control study of 300 patients undergoing percutaneous coronary intervention in which specific demographic, physician-sensitive, and nurse-sensitive factors were tested to determine their relative contribution to the incidence of vascular complications. Findings included that patients with a mean systolic blood pressure of 160 mm Hg or higher were 8 times more likely to have vascular complications (P < .001). Patients receiving heparin (with and without glycoprotein IIb/IIIa inhibitors) versus bivalirudin were 3 times more likely to have vascular complications (P = .008). Patients with hemostasis by AngioSeal and those with a history of hypertension were 77% (P =.031) and 61% (P = .005), respectively, less likely to have complications.
Related Concept Videos
Cardiac Catheterization II: Right Heart Catheterization
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Measurement of Blood Pressure
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Pre-Procedural Guidelines for Assessing Blood Pressure
